Intravenous tenecteplase administered up to 24 hours after stroke onset is associated with higher likelihood of excellent functional outcome.

Medication nonadherence in pulmonary arterial hypertension (PAH) significantly increases the risk of mortality and poor clinical outcomes.

High lipoprotein(a) levels correlated with increased risk for future cardiovascular disease among healthy women across 30 years of follow-up.

Hepatitis B vaccination at birth is safe and effective compared with a delayed first dose, according to new research.

Dilated cardiomyopathy (DCM) mortality rates in the US have declined significantly since 2004, but major sex and racial disparities persist.

One-fourth of U.S. adults are unsure if they have an increased risk for heart disease, even when they have known risk factors.

For patients with acute coronary syndrome (ACS) and cancer, the ONCO-ACS score predicts mortality, bleeding, and ischemic risk.

Both weekend warrior and regular physical activity patterns significantly reduce all-cause mortality risk in patients with hypertension.

Patients receiving complex PCI face increased risk of all-cause mortality and major bleeding, particularly those with a high bleeding risk profile.

More than four in 10 people older than 50 years (42 percent) have not gotten either a flu or COVID-19 vaccine.

The 2026 AHA/ASA guidelines for acute ischemic stroke introduce significant updates and first-ever pediatric stroke recommendations.

Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation ...